BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
- PMID: 33755373
- PMCID: PMC8008751
- DOI: 10.1056/NEJMc2101951
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
Similar articles
-
Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results.Hong Kong Med J. 2021 Aug;27(4):312-313. doi: 10.12809/hkmj219605. Epub 2021 Jun 24. Hong Kong Med J. 2021. PMID: 34413252 No abstract available.
-
Audio Interview: A New mRNA Vaccine.N Engl J Med. 2021 Jun 24;384(25):e109. doi: 10.1056/NEJMe2110531. N Engl J Med. 2021. PMID: 34161714 No abstract available.
-
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.Front Immunol. 2021 Mar 12;12:657711. doi: 10.3389/fimmu.2021.657711. eCollection 2021. Front Immunol. 2021. PMID: 33777055 Free PMC article. Review.
-
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.Ann Rheum Dis. 2021 Dec;80(12):1635-1638. doi: 10.1136/annrheumdis-2021-220862. Epub 2021 Jun 25. Ann Rheum Dis. 2021. PMID: 34172502 No abstract available.
-
Maintaining Safety with SARS-CoV-2 Vaccines.N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378605 Free PMC article. Review. No abstract available.
Cited by
-
Effectiveness of the severe acute respiratory syndrome coronavirus 2 Omicron BA.5 bivalent vaccine on symptoms in healthcare workers with BA.5 infection.Vaccine X. 2024 Jan 6;17:100433. doi: 10.1016/j.jvacx.2024.100433. eCollection 2024 Mar. Vaccine X. 2024. PMID: 38299200 Free PMC article.
-
Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February-December 2021.IJID Reg. 2023 Sep;8:19-27. doi: 10.1016/j.ijregi.2023.04.009. Epub 2023 Apr 16. IJID Reg. 2023. PMID: 37317681 Free PMC article.
-
Immunological Findings in a Group of Individuals Who Were Poor or Non-Responders to Standard Two-Dose SARS-CoV-2 Vaccines.Vaccines (Basel). 2023 Feb 16;11(2):461. doi: 10.3390/vaccines11020461. Vaccines (Basel). 2023. PMID: 36851338 Free PMC article.
-
Higher Immunological Response after BNT162b2 Vaccination among COVID-19 Convalescents-The Data from the Study among Healthcare Workers in an Infectious Diseases Center.Vaccines (Basel). 2022 Dec 15;10(12):2158. doi: 10.3390/vaccines10122158. Vaccines (Basel). 2022. PMID: 36560567 Free PMC article.
-
The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.Isr J Health Policy Res. 2022 Nov 23;11(1):39. doi: 10.1186/s13584-022-00548-3. Isr J Health Policy Res. 2022. PMID: 36419188 Free PMC article.
References
-
- Ministry of Health of Israel. Official COVID-19 data site (https://data.gov.il/dataset/covid-19). (In Hebrew.)
-
- Ministry of Health of Israel. COVID-19 research reports. 2021 (https://www.gov.il/BlobFolder/reports/research-report-n219-post-lockdown...). (In Hebrew.)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical